- The US100 index gains over 0.5% on a wave of renewed optimism in the stock market
- The US100 breaks through the 50- and 200-session exponential moving averages on the hourly interval
- J.P. Morgan expects the Fed to end quantitative tightening (QT) next week
- The US100 index gains over 0.5% on a wave of renewed optimism in the stock market
- The US100 breaks through the 50- and 200-session exponential moving averages on the hourly interval
- J.P. Morgan expects the Fed to end quantitative tightening (QT) next week
The US stock market gains today amid optimism around possible Fed rate cut next week, positive Q4 seasonality patterns, strong earnings season and stronger than expected data from Kansas City Fed. Kansas Fed Composite Index came in at 6 vs 2 exp. and 4 previously, while the manufacturing benchmark rose to 15 vs 4 previously. J.P Morgan analysts pointed to the end of the quantitive tightening (QT) program by the Fed in October. Such a scenario could improve investor sentiments around US bonds and stock market. US100 is up more than 0.5% today, surging above 25150 points. The index tries to recover and rise above near ATH level again despite not optimistic Wall Street reaction to Tesla's and Netflix earnings reports.
Source: xStation5
NATGAS loses after the EIA inventories report
Stock of the Week - Merck & Co Inc (23.10.2025)
US Open: Mixed sentiments on Wall Street 📊IBM loses, Honeywell surges 7%
BREAKING: OIL gain extends to 3.5% 📈Chinese state companies stop Russian oil purchases
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
